Anika Therapeutics, Inc.: accounts_receivable
| Value | {"amount": 23600000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-01-01) |
| Status | current |
| Entity | Anika Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/feaf3ec7-171a-4b76-9551-5973b490dd0c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-26-005012Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000898437/accounts-receivable/2025-01-01 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/feaf3ec7-171a-4b76-9551-5973b490dd0c
History
- no predecessors — first report